{"schema_version":"1","generated_at":"2026-10-31T14:55:45.726Z","data_as_of":null,"url":"https://www.findmykol.com/kol/john-sweetenham","json_url":"https://www.findmykol.com/kol/john-sweetenham/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"john-sweetenham","name":"John Sweetenham","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Harold C. Simmons Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/harold-c-simmons-comprehensive-cancer-center","city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1942267083","orcid":"0000-0002-9873-2060","openalex":"A5072154632"},"summary":"John Sweetenham is an Oncology physician affiliated with Harold C. Simmons Comprehensive Cancer Center. OpenAlex indexes 302 publications with 10,952 citations (h-index 42); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":302,"cited_by_count":10952,"h_index":42,"latest_activity_year":2024,"source":"works"},"trials":{"count":3,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00896922","title":"S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911","status":"COMPLETED","role":"Overall official","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT00896922","trial_url":"https://www.findmykol.com/trial/NCT00896922"},{"nct":"NCT00768339","title":"A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Aegera Therapeutics","source_url":"https://clinicaltrials.gov/study/NCT00768339","trial_url":"https://www.findmykol.com/trial/NCT00768339"},{"nct":"NCT00015912","title":"Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT00015912","trial_url":"https://www.findmykol.com/trial/NCT00015912"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Coherus Biosciences Inc.","program_year":2022,"amount_usd":36.76,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1942267083"},{"payer":"BeiGene USA, Inc.","program_year":2021,"amount_usd":95.24,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1942267083"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1942267083","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Enhancing Readability of Online Patient-Facing Content: The Role of AI Chatbots in Improving Cancer Information Accessibility","year":2024,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2023.7334","status":"verified"},{"title":"Screen to Save: Results from NCI's Colorectal Cancer Outreach and Screening Initiative to Promote Awareness and Knowledge of Colorectal Cancer in Racial/Ethnic and Rural Populations","year":2020,"journal":"Cancer Epidemiology Biomarkers & Prevention","source_url":"https://doi.org/10.1158/1055-9965.epi-19-0972","status":"verified"},{"title":"Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse","year":2018,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2018-07-861641","status":"verified"},{"title":"US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816","year":2016,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2015.63.1119","status":"verified"},{"title":"Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2015,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(15)60165-9","status":"verified"}],"source":"works"},"contact":{"address_1":"2201 INWOOD RD # NC2.130","city":"Dallas","state":"TX","zip":"75235","phone":"241-645-4673","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1942267083","source":"identity"},"similar":[{"name":"Herbert Zeh","slug":"herbert-zeh","institution":"Harold C. Simmons Comprehensive Cancer Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/herbert-zeh","json_url":"https://www.findmykol.com/kol/herbert-zeh/profile.json"},{"name":"John Minna","slug":"john-minna","institution":"Harold C. Simmons Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/john-minna","json_url":"https://www.findmykol.com/kol/john-minna/profile.json"},{"name":"Carlos Arteaga","slug":"carlos-arteaga","institution":"Harold C. Simmons Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carlos-arteaga","json_url":"https://www.findmykol.com/kol/carlos-arteaga/profile.json"},{"name":"Hans Hammers","slug":"hans-hammers","institution":"Harold C. Simmons Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hans-hammers","json_url":"https://www.findmykol.com/kol/hans-hammers/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2019-04-19","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}